APA (7th ed.) Citation

JL, R. G., JM, B., I, B. R., M, C. S., & C, S. F. (2025). Thromboembolic phenomena in inflammatory bowel disease and risk with JAK inhibitor treatments. Gastroenterologia y hepatologia, 48(1), 502257. https://doi.org/10.1016/j.gastrohep.2024.502257

Chicago Style (17th ed.) Citation

JL, Rueda García, Benitez JM, Baston Rey I, Calafat Sard M, and Suárez Ferrer C. "Thromboembolic Phenomena in Inflammatory Bowel Disease and Risk with JAK Inhibitor Treatments." Gastroenterologia Y Hepatologia 48, no. 1 (2025): 502257. https://doi.org/10.1016/j.gastrohep.2024.502257.

MLA (9th ed.) Citation

JL, Rueda García, et al. "Thromboembolic Phenomena in Inflammatory Bowel Disease and Risk with JAK Inhibitor Treatments." Gastroenterologia Y Hepatologia, vol. 48, no. 1, 2025, p. 502257, https://doi.org/10.1016/j.gastrohep.2024.502257.